SEC Filing Summary: ETHZilla Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ETHZilla Corporation (formerly 180 Life Sciences Corp.) on August 18, 2025. The filing reports a corporate name change effective as of the filing date. The company is incorporated in Delaware and maintains its principal executive offices in Palm Beach, Florida. Its common stock (ETHZ) and warrants (ETHZW) trade on The NASDAQ Stock Market LLC.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name Change: The registrant officially changed its name from "180 Life Sciences Corp." to "ETHZilla Corporation" effective August 18, 2025.
- Trading Symbols: The filing confirms the trading symbols ETHZ (Common Stock) and ETHZW (Warrants) on NASDAQ.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document strictly serves to disclose the name change pursuant to Regulation FD (Item 7.01) and lists the associated press release as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the effective date of the name change (August 18, 2025) and confirm the transition of the ticker symbol or corporate identity on trading platforms.
- Review the attached press release (Exhibit 99.1) for strategic rationale behind the rebranding from a life sciences focus to the new "ETHZilla" identity.
- Confirm that the change in name does not alter the company's existing securities registration or outstanding warrant obligations.